Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Interdisciplinary Toxicology
Volume 12 (2019): Issue 3 (November 2019)
Open Access
General toxicity assessment of the novel aldose reductase inhibitor cemtirestat
Marta Šoltésová Prnová
Marta Šoltésová Prnová
,
Lucia Račková
Lucia Račková
,
Lucia Kováčiková
Lucia Kováčiková
,
Jana Balleková
Jana Balleková
,
Jana Viskupičová
Jana Viskupičová
,
Silvia Micháliková
Silvia Micháliková
,
Betul Taşkoparan
Betul Taşkoparan
,
Zübeyir Elmazoğlu
Zübeyir Elmazoğlu
,
Tea Lanišnik Rižner
Tea Lanišnik Rižner
,
Cimen Karasu
Cimen Karasu
,
Sreeparna Banerjee
Sreeparna Banerjee
and
Milan Štefek
Milan Štefek
| Feb 20, 2020
Interdisciplinary Toxicology
Volume 12 (2019): Issue 3 (November 2019)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 20, 2020
Page range:
120 - 128
Received:
Jul 22, 2019
Accepted:
Sep 15, 2019
DOI:
https://doi.org/10.2478/intox-2019-0014
Keywords
cemtirestat
,
aldose reductase inhibitor
,
toxicity assessment
© 2019 Marta Šoltésová Prnová et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Marta Šoltésová Prnová
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Lucia Račková
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Lucia Kováčiková
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Jana Balleková
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Jana Viskupičová
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Silvia Micháliková
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia
Betul Taşkoparan
Department of Biological Sciences, Middle East Technical University
Ankara, Turkey
Zübeyir Elmazoğlu
Department of Biological Sciences, Middle East Technical University
Ankara, Turkey
Tea Lanišnik Rižner
Institute of Biochemistry, Faculty of Medicine, University of Ljubljana
Slovenia
Cimen Karasu
Department of Medical Pharmacology, Faculty of Medicine, Gazi University
Ankara, Turkey
Sreeparna Banerjee
Department of Biological Sciences, Middle East Technical University
Ankara, Turkey
Milan Štefek
Department of Biochemical Pharmacology, Institute of Experimental Pharmacology and Toxicology, CEM, Slovak Academy of Sciences
Bratislava, Slovakia